Abstract
Carcinoma of the endometrium is the most common gynecologic malignancy in the United States, accounting for 38,000 new cases and 3,200 deaths every year [1]. Although surgery and radiation therapy are quite effective and achieve 80–90% cure rates in early stages, most of the fatalities occur in patients with advanced, recurrent, or metastatic disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Silverberg E, 1982. Cancer statistics. CA 32:18–42.
Kelley RM, Baker WH, 1960. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 264:216–222.
Deppe E, 1984. Chemotherapy of endometrial carcinoma. In Chemotherapy of Gynecologic Cancer, (Deppe D, ed) New York: Alan R. Liss, pp. 139–150.
Jensen EU, DeSombre ER, 1972. Mechanism of action of female sex hormones. Annu Rev Biochem 41:203–230.
Gorski J, Ganong F, 1976. Current models of steroid hormone action: A critique. Annu Rev Physiol 38:425–450.
McGuire WL, Carbone PO, Vollmer EP, 1975. Estrogen Receptors in Human Breast Cancer. New York: Raven Press.
Allegra JC, Lippman ME, Thompson EB, Simon R, Bartock A, Green L, Hupp KK, Do HMI, Aitken SC, Warren R, 1978. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Treat Rep 62:1281–1286.
McGuire WL, 1978. Hormones, Receptors and Breast Cancer. New York: Raven Press.
Mortel R, Zaino RJ, Satyaswaroop PG, 1984. Sex steroid receptors and hormonal treatment of endometrial cancer. In Chemotherapy of Gynecologic Cancer, (Deppe G, ed). New York: Alan R Liss pp. 125–138.
Martin PM, Rolland PH, Gammere M, Serment H, Toga M, 1979. Estradiol and progesterone receptors in normal and neoplastic endometriums: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 24:324–329.
Benraad TJ, Friberg LG, Koenders AJM, Kullander S, 1980. Do estrogen and progesterone receptors in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand 59:155–159.
Creasman WT, McCarty KS,Sr, Barton TK, McCarty KS,Sr, 1980. Clinical correlates of estrogen and progesterone binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55:363–370.
McCarty KS,Jr, Barton TK, Fetter BF, Creasman WT, McCarty KS,Sr, 1979. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol 96:171–183.
Martin PM, 1982. Endometrial cancer: Correlations between estrogen and progestin receptor status, histopathological findings, and clinical responses during progestin therapy. Excerpta Med Int Can Series 611:333–349.
Mortel R, Levy C, Wolff J-P, Nicholas J-C, Robel P, Baulieu E-E, 1981. Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to antiestrogen. Cancer Res 41:1140–1147.
Satyaswaroop PG, Mortel R, 1982. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma. Cancer Res 42:1322–1325.
Mortel R, Zaino RJ, Satyaswaroop PG, 1984. Heterogeneity and progesterone receptor distribution in endometrial adenocarcinoma. Cancer 53:113–116.
Satyaswaroop PG, Zaino R, Mortel R, 1983. Human endometrial adenocarcinoma transplanted into nude mice: Growth regulation by estradiol. Science 219:58–60.
Satyaswaroop PG, Zaino RJ, Mortel R, 1987. Steroid receptors and human endometrial carcinoma: Studies in a nude mouse model. Ca Metastas Rev 6:223–241.
Clarke CL, Satyaswaroop PG, 1985. Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma. Cancer Res 45:5417–5420.
Satyaswaroop PG, Zaino RJ, Mortel R, 1984. Estrogen-like effect of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44:4006–4010.
Zaino RJ, Satyaswaroop PG, Mortel R, 1984. Morphology of human uterine cancer in nude mice. Arch Pathol Lab Med 108:571–578.
Zaino RJ, Satyaswaroop PG, Mortel R, 1985. Hormonal therapy of human endometrial carcinoma in a nude mouse model. Cancer Res 45:539–541.
Mortel R, Satyaswaroop PG, Clarke CL, Zaino R, 1986. Sex steroid receptors in normal and malignant endometrium. Ann Pathol 6:109–114.
Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, Ohlsson-Wilhelm BM, Satyaswaroop PG, 1987. Monoclonal antibodies to human progesterone receptor: Characterization by biochemical and immunohistochemical techniques. Endocrinology 121:1123–1132.
Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG, 1988. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 48:1889–1895.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Satyaswaroop, P.G., Zaino, R.J., Mortel, R. (1989). Carcinoma of the endometrium and hormonal receptors. In: Surwit, E.A., Alberts, D.S. (eds) Endometrial Cancer. Cancer Treatment and Reasearch, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0867-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0867-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8210-5
Online ISBN: 978-1-4613-0867-6
eBook Packages: Springer Book Archive